✦ LIBER ✦

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy

✍ Scribed by Kakolyris, S; Souglakos, J; Agelaki, S; Kourousis, Ch; Mavroudis, D; Sarra, E; Malliotakis, P; Georgoulias, V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line docetaxel and gemcitabine co

✍ Faruk Tas; Cumhur Demir; Hakan Camlica; Zeki Ustuner; Erkan Topuz 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 95 KB

Phase I trial of dose escalation of cape

✍ Qiang Lin; Yue’e Liu; Chuilin Chang; Na Wang; Jingmei Fu; Xiaocang Ren; Xueji Ch 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 260 KB

Chemotherapy-induced neutropenia as a pr

✍ Pallis, A.G.; Agelaki, S.; Kakolyris, S.; Kotsakis, A.; Kalykaki, A.; Vardakis, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Phase II Study of Docetaxel/Vinorelbine

✍ Alberto Muñoz; Itziar Rubio; Juan Manuel Mañé; Josefa Ferreiro; Ricardo Fernánde 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 140 KB

A phase I trial of combination chemother

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A phase I study of CPT-11 in combination

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 118 KB